S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7125 +0.22%
PRE-MKT · 07:20 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
KD
INSIDER · FDMT · 4D Molecular Therapeutics, Inc. · SEE REMARKS

Kirn David

Every open-market transaction filed under this name, Aug 19 to Oct 5.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$2.7M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 5FDMT4D Molecular Therapeutics, Inc.See RemarksSell272$13.61$4K−7.3%
Oct 5FDMT4D Molecular Therapeutics, Inc.See RemarksSell58,061$12.92$750K−2.3%
Sep 14FDMT4D Molecular Therapeutics, Inc.See RemarksSell58,333$13.90$811K−9.2%
Aug 19FDMT4D Molecular Therapeutics, Inc.See RemarksSell25,927$16.42$426K−23.1%
Aug 19FDMT4D Molecular Therapeutics, Inc.See RemarksSell43,149$15.36$663K−17.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.